<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">We found that the high-risk factors for the prognosis of patients with COVID-19 are not only related to the specific population, but also highly related to the treatment drugs in the acute phase. For example, the use of a large number of interferon in the treatment of coronavirus will lead to emotional depression, anxiety, short-term memory disorders of sleep disorders through the impact on endocrine and changes in neurotransmitter and immune system changes [
 <xref ref-type="bibr" rid="CR34">34</xref>]; meanwhile, high dose of exogenous steroids can cause reversible memory damage through the effect on hippocampal metabolism [
 <xref ref-type="bibr" rid="CR35">35</xref>].
</p>
